For instance, in a breast cancer model in mice, blockade of VCAM-1 reduced tumor LVI, presumably due to its role in destabilizing lymphatic endothelial junctions by engaging α4β1 integrin on adjacent LECs [79]. This evidence concerns the gene VCAM1 and breast carcinoma.